Europe: Patient care with innovative medical products will become more difficult
31 January 2019
|Results of a business survey
The companies in this sector, which is mainly characterised by medium-sized enterprises, expect considerable difficulties in bringing innovations to market in the future: 79 % of the companies see this as a serious consequence the MDR. Almost three quarters of all companies see cost increases in market access with great or even very great concern. Every third company even considers his existence at risk.
Many companies are planning to withdraw products from the European market so that they will no longer be available for healthcare.
|DIHK | Deutscher Industrie- und Handelskammertag e.V., SPECTARIS. Deutscher Industrieverband für optische,
medizinische und mechatronische Technologien e.V.
|Self-published, Vogel Verlag, Jan 2019 (german)|
|This is a post of a scientific or business information. The information given here is checked thoroughly by “Implant-Register”. However we can´t be responsible for the content. Contact the publisher, if you have questions. You may inform us about changes of the information to improve the Register.|
let us know
Find NEWS and PUBLICATIONS here according to your interests or use the search box.